Together to cure pediatric and adult Sarcomas
Our mission is to support research and initiatives that offer children, adolescents, and adults with sarcoma the best chances to heal and fully recover
Pediatric and young adult sarcomas
Sarcomas are divided into bone and soft tissue sarcomas. They represent 20% of children and 13% of young adults solid tumors and their incidence is 10-15% of all pediatric tumors. The prognosis of metastatic or recurrent sarcomas is poor. In order to improve the outcome of sarcomas and their treatments, fundamental and clinical research is highly needed.
Our Vision
Our vision is inspired by Dania's wish: that all children, adolescents and adults diagnosed with sarcoma can fully recover with minimal side effects.
The difference you will make
Cancer is the leading cause of disease-related death in children. Despite progresses and improvements in the overall survival rates for many cancers throughout the years, the prognosis for children with metastatic, refractory, or relapsed sarcomas is grim, with an overall survival rate of less than 20%. The Dania Kayali Foundation is committed to support research and initiatives to help cure children, adolescents, and adults with sarcomas .
The Story Of Dania
In 2016, at the age of 15, Dania was diagnosed with Osteosarcoma (Bone Cancer). After a leg surgery and months of intense chemotherapy, Dania's remission did not last long. The cancer relapsed in the lungs forcing her to go through multiple surgeries and cycles of chemotherapy. In spite of the hardship caused by her battle against cancer, Dania continued to embrace the hope that one day science and research will be able to cure relapsed cancers. She made us promise to continue her battle until all pediatric and young adult sarcomas can be cured. Dania died peacefully on January 3rd, 2021.
Dania Kayali ( 2001-2021)
Sarcomas, their treatments and Research needs
Dr. Nicolas Prud'homme
MD, MSc, FRCPC
Hémato-oncologue Pédiatrique
CHU Sainte-Justine
Dania's Story told by her Mother Nathalie
